韩国国家养老金服务局在2025年Q3将其Merck股份增加到570万股,价值4.79亿美元。 South Korea's National Pension Service boosted its Merck stake to 5.7 million shares in Q3 2025, worth $479 million.

韩国国家养老金服务局在2025年3月将Merck & Co.的股份增加了175 582股,将所有权提高到570万股,即0.23%,价值约4.79亿美元。 The National Pension Service of South Korea increased its stake in Merck & Co. by 175,582 shares in Q3 2025, raising its ownership to 5.7 million shares, or 0.23%, valued at about $479 million. Merck报告Q3收入为每股1.94美元,略低于2.08美元的估计数,并宣布季度红利为每股0.85美元,收益率为3.1%。 Merck reported Q3 earnings of $1.94 per share, slightly below the $2.08 estimate, and announced a quarterly dividend of $0.85 per share, yielding 3.1%. 股价为110.24美元,市场上限为273.62亿美元,具有一致的“稳住”评级,目标价格为114.53美元。 The stock, trading at $110.24 with a market cap of $273.62 billion, has a consensus "Hold" rating and a target price of $114.53. 对Keytruda和新产品发射的强劲需求支持了库存,尽管不断上涨的合并和收购成本和分析师估计值的下降带来了近期风险。 Strong demand for Keytruda and new product launches support the stock, though rising M&A costs and declining analyst estimates pose near-term risks.